A scheme is presented that shows how the reactions involved in gluconeogenesis, glycolysis and the tricarboxylic acid cycle are linked in rat liver. Equations are developed that show how label is redistributed in aspartate, glutamate and phosphopyruvate when it is introduced as specifically labelled pyruvate or glucose either at a constant rate (steady-state theory) or at a variable rate (non-steady-state theory). For steady-state theory the fractions of label introduced as specifically labelled pyruvate that are incorporated into glucose and carbon dioxide are also given, and for both theories the specific radioactivities of aspartate and glutamate relative to the specific radioactivity of the substrate. The theories allow for entry of label into the tricarboxylic acid cycle via both oxaloacetate and acetyl-CoA, for 14CO2 fixation and for loss of label from the tricarboxylic acid cycle in glutamate, but not for losses in citrate. They also allow for incomplete symmetrization of label in oxaloacetate due to incomplete equilibration with fumarate both in the extramitochondrial part of the cell and in the mitochondrion on entry of oxaloacetate into the tricarboxylic acid cycle. In the latter case failure both of oxaloacetate to equilibrate with malate and of malate to equilibrate with fumarate are considered.
A scheme is presented that shows how the reactions involved in gluconeogenesis, glycolysis and the tricarboxylic acid cycle are linked in rat liver. Equations are developed that show how label is redistributed in aspartate, glutamate and phosphopyruvate when it is introduced as specifically labelled pyruvate or glucose either at a constant rate (steady-state theory) or at a variable rate (non-steady-state theory). For steady-state theory the fractions of label introduced as specifically labelled pyruvate that are incorporated into glucose and carbon dioxide are also given, and for both theories the specific radioactivities of aspartate and glutamate relative to the specific radioactivity of the substrate. The theories allow for entry of label into the tricarboxylic acid cycle via both oxaloacetate and acetyl-CoA, for 14CO2 fixation and for loss of label from the tricarboxylic acid cycle in glutamate, but not for losses in citrate. They also allow for incomplete symmetrization of label in oxaloacetate due to incomplete equilibration with fumarate both in the extramitochondrial part of the cell and in the mitochondrion on entry of oxaloacetate into the tricarboxylic acid cycle. In the latter case failure both of oxaloacetate to equilibrate with malate and of malate to equilibrate with fumarate are considered.
In the liver the reactions involved in gluconeogenesis, glycolysis and the tricarboxylic acid cycle are interlinked. Krebs, Hems, Weidemann & Speake (1966) pointed out that attempts to calculate the rates of these reactions from experiments with 14C either in perfused organs or in vivo were often frustrated because the redistribution of label along the pathways had not been worked out.
With any specifically labelled pyruvate or glucose as substrate experimental methods exist for determining the distribution of label within glucose, glutamate and aspartate, and the relative specific radioactivities of glucose, glucose 6-phosphate, pyruvate, aspartate and glutamate; and with any specifically labelled pyruvate as substrate for determining the fractions of label incorporated into carbon dioxide and glucose, i.e., by chemical analogy, the yields of 14CO2 and [14C]glucose (Ashby, Heath & Stoner, 1965) . The aim here is to relate algebraically these distributions of label, relative specific radioactivities and yields to the rates of the reactions involved for the particular case of the rat liver.
Rat liver was chosen because most is known about it. In the kidneys some enzymes may be differently distributed between the mitochondrion and the extramitochondrial part of the cell (cytoplasm), and in the livers of some other species one enzyme is known to be differently distributed. For rat liver the basic scheme is taken to be that in Scheme 1, which is based on the work of many authors (e.g. Krebs et al. 1966; Walter, Paetkau & Lardy, 1966; Henning, Stumpf, Ohly & Seubert, 1966) . Lorber, Lifson, Wood, Sakami & Shreeve (1950) gave a semi-quantitative discussion of the interactions of the tricarboxylic acid cycle and gluconeogenesis that foreshadows the present one in several respects, and Weinman, Strisower & Chaikoff (1957) and Exton & Park (1967) have given preliminary algebraical treatments based on the same principles as the present one.
As the system: oxaloacetate = malate fumarate in the tricarboxylic acid cycle can be treated in three ways (see under '3. Steady-state theory' in the Theory section) and at least two of these treatments must be combined to correlate experimental results (Heath & Threlfall, 1968) 
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Scheme 1. Basic scheme for the interaction of glycolysis, gluconeogenesis and the tricarboxylic acid cycle. Most of the variables used in deriving equations are defined by this Scheme. Within dashes: mitochondrial processes; within dots: both intra-and extra-mitochondrial processes; outside dots and dashes: extramitochondrial (cytoplasmic) processes. similar dilution of aspartate label. Inclusion of the first two has been shown to have negligible effects on the treatment (Heath & Threlfall, 1968) ; inclusion of the third would result in a lowering of all specific radioactivities relative to glucose 6-phosphate, without altering yields or the distribution of label within compounds; inclusion of the last two would result only in a lowering of the specific radioactivities of glutamate and aspartate relative to the other specific radioactivities. Heath & Threlfall (1968) also discuss these dilution processes in the light of experimental findings.
The transfer of radioactivity without net flux of compound (exchange) is considered in the Discussion section and by Heath & Threlfall (1968) , and is shown to be allowed for adequately by the scheme.
The substrates considered are specifically labelled pyruvate and glucose. It is assumed either that the substrates are introduced at such low concentrations that they do not alter any chemical concentrations appreciably, or that they are introduced at a steady rate which maintains the concentrations constant. In the first case labelled lactate and for many purposes alanine are equivalent to pyruvate labelled in the same positions. In the second they may not be, and results refer to the particular balance of pathways set up by the steady substrate concentration.
Both an isotopic steady-state theory and an isotopic non-steady-state theory are developed. For the steady-state theory the specific radioactivity of the substrate is assumed to remain constant throughout an experiment long enough for label to equilibrate in the system and for its distribution to become time-invariant. This corresponds to intravenous infusion and the situation in some perfusions of isolated organs. For the non-steady-state theory the specific radioactivity of the substrate is supposed Threlfall & Heath (1968) have shown that the glycolytic and gluconeogenic chains are separated between glucose and the triose phosphates, and may be at the triose phosphate level also. It is irrelevant to the mathematical treatment whether the chains are also separated to PEP or whether they are only separated to the triose phosphates, provided that these are in equilibrium with PEP. [Separation to PEP is in accordance with, e.g., some findings ofFellenberg, Eppenberger, Richterich & Aebi (1962) , Krebs (1963 ), Ashby et al. (1965 , Exton & Park (1965) and Heath & Threlfall (1968).] Threlfall & Heath (1968) showed that most of the liver glucose 6-phosphate was in the glycolytic chain, so that in glucose 6-phosphate label from glucose was much diluted by glucose 6-phosphate from glycogen. For this reason when labelled glucose is the primary substrate specific radioactivities are calculated relative to that of glucose 6-phosphate, and an allowance is made for the dilution of glucose label.
PEP -+ pyruvate. The reaction is mediated by pyruvate kinase (ADP-pyruvate phosphotransferase, EC 2.7.1.40) in the cytoplasm. It is taken as irreversible, in accordance with experiments in vivo (Hornbrook, Burch & Lowry, 1965) and in vitro (Utter, 1959) . Observations earlier explained by its reversal (Hoberman & d'Adamo, 1960) can now be * Abbreviation: PEP, phosphoenolpyruvate.
explained in other ways (Seubert & Huth, 1965 ; and see below under '2. Redistribution of label').
Pyruvate -. acetyl-CoA -+ tricarboxylic acid cycle. (Walter et al. 1966 ), but in starved rats up to half may be cytoplasmic (Seubert & Huth, 1965 Oxaloacetate -* PEP. This is mediated by phosphopyruvate carboxylase [GTP-oxaloacetate carboxy-lyase (transphosphorylating), EC 4.1.1.32], which in the rat, unlike in some other species, is almost wholly cytoplasmic (Nordlie & Lardy, 1963; Nordlie, Varricchio & Holten, 1965) . The reaction is reversible, but goes very much faster in the direction shown under physiological conditions (Chang, Maruyama, Miller & Lane, 1966 Transport of oxaloacetate, malate and/or fumarate from the mitochondrion to the cytoplasm. Krebs, Gascoyne & Notton (1967) pointed out that to provide NADH for the conversion of diphosphoglycerate into glyceraldehyde phosphate a reduced intermediate must leave the mitochondrion, and not oxaloacetate. They suggested malate. Applica. tion of the present theory leads independently to the conclusion that the compound transported is not oxaloacetate, but could be malate or fumarate or both.
The two major omissions are:
Citrate -÷ oxaloacetate + acetyl-CoA. This is the lipogenic process (see the introduction) utilizing citrate from the tricarboxylic acid cycle (Srere, 1965 . These authors agree that this enzyme is not very active.
At certain points some processes are described as irrelevant. This does not mean that they do not take place, or that they are metabolically unimportant. It does mean that the theory does not depend on them. (Hers, 1957; Rauschenbach & Lamprecht, 1964), C1,2,3-and C4,5,6 -labelling in glucose may be unequal. The pentose shunt causes erosion and randomization of glucose label that first affects the Cl-position (see, e.g., Wood, Katz & Landau, 1963) . Both effects are fairly small, and are neglected in the present treatment. The pentose shunt is unlikely to affect C4,5,6-labelling in glucose, as, to affect these positions, the shunt has to be very fast with much recycling. Therefore it is assumed that:
(2.1) The relative labelling in the Cl-, C2-and 03-positions in PEP is reflected precisely in the relative labeUing in the C4-, C5-and C6-positions in the glucose formed from PEP.
(2.2) On glycolysis C4-glucose will give Cl-PEP, C5-glucose will give C2-PEP and C6-glUcose will give C3-PEP.
(2.3) C(U)-glucose (uniformly labelled) gives uniformly labelled PEP on glycolysis.
Scheme 3 shows the conversion of pyruvate into PEP via oxaloacetate.
(2.4) In forming oxaloacetate any label in carbon dioxide will label oxaloacetate in the C4-position, and in forming PEP all C4-label in oxaloacetate is lost as 14CO2. Extensive C3,4-labelling was found by Lorber et al. (1950) which, from statements (2.7) and (2.9), shows that tricarboxylic acid-cycle pathways can contribute to gluconeogenesis.
Only those moieties which come from C2-pyruvate and which also enter the tricarboxylic acid cycle via acetyl-CoA can label the C5-position in 2-oxoglutarate. Label in liver glutamate reflects labelling in 2-oxoglutarate. Hence: (2.10) The (C5-label in glutamate)/(total label in glutamate) ratio, abbreviated to (C5-Glu)/(T-GIu), found after C2-pyruvate injection indicates the relative contribution8 made by the two pathway8, entry via acetyl-CoA and entry via oxaloacetate (Freedman & Graff, 1958; Koeppe, Mourkides & Hill, 1959 3. Steady-8tate theory Three variables in addition to those shown in Scheme 1 are required.
(1) In the cytoplasm passage of label through oxaloacetate may not be accompanied by complete symmetrization (statements 2.5 and 2.6). The fraction of label that retains its position from pyruvate through oxaloacetate to PEP is denoted by a. Scheme 6 shows in terms of a how label is redistributed.
(2) When pyruvate moieties enter the tricarboxylic acid cycle as oxaloacetate the label in oxaloacetate may not be completely symmetrized on entry before it reacts with citrate synthase. Existing data can only be correlated if symmetrization on entry is incomplete (Heath & Threlfall, 1968) . The fraction that is not symmetrized is denoted by z. It should be noted that z is not the algebraical equivalent of a.
(3) Label can fail to be symmetrized on entry into the cycle in two ways: either because malate fails to equilibrate with fumarate (Scheme 7a) or because it fails to equilibrate with oxaloacetate (Scheme 7b). The two cases give different equations. Therefore three cases are worked out: the case with complete symmetrization (sym. case); the case with no symmetrization because fumarate does not equilibrate with malate (non-sym. case A); and the case with no symmetrization because oxaloacetate does not equilibrate with malate (non-sym. case B). The fractions of input of label obeying non-sym. . To develop equations label is supposed to enter the system at a constant rate in a specific position either in pyruvate or in PEP from glucose (statement 2.2) via glucose 6-phosphate. As:
Specific radioactivity = flow of compound( the specific radioactivity of each carbon in the system can be directly calculated as far as 2-oxoglutarate in terms of the rate of entry of label in pyruvate or PEP. It is mathematically convenient to divide the tricarboxylic acid cycle between 2-oxoglutarate and succinate, and to denote this Specific radioactivities are now calculated relative to this new input, which is itself related to the original input in pyruvate or PEP. And so on for successive turns of the cycle to infinity. The treatment therefore gives the specific radioactivity of each position in each compound for each turn of the cycle, and the results are tabulated in this form in the Appendix. The total specific radioactivity of any position of labelling is obtained by summing the specific radioactivities calculated for every turn of the cycle to infinite turns.
One example is worked out in detail, namely labelling from C2-pyruvate on non-sym. case B, and another in fair detail, namely C2-pyruvate on sym. case, to show the approach. There are in all nine sets of equations: three cases, and for each case the labelling from Cl-, C2-and C3-pyruvate.
C2-pyruvate, non-sym. case B. The parameters are as in Schemes 1 and 7(b). There is no equilibration between oxaloacetate and fumarate in the tricarboxylic acid cycle. This implies very low oxaloacetate concentrations, so that losses must be as malate or fumarate or both, not as oxaloacetate, and these receive no label except from 2-oxoglutarate.
Denote the specific radioactivities of pyruvate, PEP, 2-oxoglutarate and malate (=_fumarate) by Sp, Svpq Sk and Sm, and those of oxaloacetate in the tricarboxylic acid cycle and in the cytoplasm by Sol and So2 respectively. Numerals in ordinary type in parentheses after 'C' denote positions labelled. Italicized numerals merely enumerate derived parameters. They are chosen here to correspond to those in the full programme of nine cases, so they are not always in the order expected in the small part presented here. Let label enter at rate V1, solely in the C2-position in pyruvate. Let the label in PEP be divided between the C2-and C3-positions in the ratio: So2(C2) = A(2)5p(C2); So2(C3) = A(2)Sp(C3) (3.13) (Here and throughout the label given for oxaloacetate in the cytoplasm is that before symmetrization.) The fraction of label that retains its position in passing through oxaloacetate is oc (see above).
Hence:
(3.14)
Substituting eqns. (3.4), (3.5) and (3.10) in eqn. (3.13), and eqn. (3.13) in eqn. (3.14), separating variables and rearranging gives:
and substitute in eqns. (3.4), (3.5) and (3.10).
Then:
The labelling in 2-oxoglutarate can be estimated from the relationships:
This completes the zeroth turn of the cycle.
Label is symmetrized via succinate, so that:
The number of primes corresponds to the number of turns of the cycle. (V2+ V3-I.) and similarly for S'02(C2), S02(C3) and S0'2(C4).
(Vl + V6) S;(C2) = S,(C3) = S,P(C2) = S;P(C3) (3) 
This ends the first turn of the cycle. As Sk(C5) =Sk(C4) and Sk(C3) =Sk(C2), it follows from eqn. 1 + E(1) + E(1)2 + **.
the required specific radioactivities can be written down.
Label is also introduced by 14CO2 fixation (statement 2.4). It is assumed that, as the liver releases carbon dioxide rapidly mostly from the tricarboxylic acid cycle, the 14CO2 released is not diluted by less heavily labelled carbon dioxide from other organs. As the contribution made by 14CO2 fixation is fairly small, very little error will be introduced if this assumption is not quite right. Then:
Rate of release of CO2 (unlabelled) = R (citrate -+ 2-oxoglutarate)
Rate of evolution of 14CO2 = V1Y2(C02), where Y2(CO2) is the fraction of label introduced as C2-pyruvate that is incorporated into carbon dioxide, i.e. the yield of 14CO2 from C2-pyruvate (see the introduction).
Hence, if C2 is the specific radioactivity of carbon dioxide from C2-pyruvate, from eqn. Bioch. 1968, 110 321 Vol. 110
whence, with eqn. (3.40) in eqn. (3.41), and simplifying with eqns. (3.9) and (3.11):
All label is lost as 14CO2 except that accounted for above.
In listing the final formulae the following factors are considered.
(1) Label is measured in aspartate and glutamate, not in oxaloacetate and 2-oxoglutarate. Specific radioactivities are therefore referred to the amino acids. In the steady state these must, of course, equal those in the oxo acids.
(2) In glutamate the position labelled is denoted as n, i.e. Gltu(n) is the specific radioactivity of the nth position in glutamate.
(3) For aspartate the distribution of label may be between that of the oxaloacetate from which it is formed and that formed from it which goes to PEP. Therefore detailed labelling is not given, only the specific radioactivities Asp(1,4) and A8p(2,3), as the amounts in these combined positions are unaffected by this uncertainty. (Numerically the uncertainty is small, and the values for individual positions could be bracketed closely from the equations.) (4) When the primary substrate is pyruvate, the specific radioactivity of glucose rarely in practice approaches that of PEP because [14C]glucose is diluted by a big pool of unlabelled glucose. Specific radioactivities in PEP are therefore given, denoted by PP(n). The distribution of label is the same in C4,5,6-glucose as in C1,2,3-PEP.
(5) On the scale implied by the treatment the specific radioactivity of intracellular pyruvate is given by 1 +PP(1) +PP(2) +PP(3), and the specific radioactivity of the input pyruvate by 1.
Thus:
Denote the yield of glucose by Y2(Glc). The rate of labelling of glucose is V6 x specific radioactivity of PEP, and the rate of input of label into the system is Vi. Hence the fraction of the label entering glucose, i.e. the yield, is: (2) Spv(C2) = 8Sv(C2,3); Spp(C3) = (1 -S)S,P(C2,3) = S5(C3); S5(C2) = 1 +Sp(C2) (3.57) by analogy with eqns. (3.4), (3.5) and (3.6).
As label is symmetrized on entering the tricarboxylic acid cycle:
SO1 ( The remaining equations are developed as before.
Glucose as substrate. In the symbolism of Scheme 1 the glucose/(glucose 6-phosphate) specific-radioactivity ratio is given by:
Ril/(Ri +R2) (3.67) Specific radioactivities of pyruvate, glutamate and aspartate cannot therefore be related to those of glucose except via eqn. (3.67) (if R1 and R2 are known) or by the empirical determination of the relative specific radioactivities of the two compounds. Specific radioactivities are therefore given relative to those in specifically labelled glucose 6-phosphate.
Suppose that for any case (sym., non-sym. A or non-sym. B) and any position of labelling, C4-, C5-or C6-, label flows from glucose 6-phosphate to PEP at unit rate. Then, as the total flow of material through PEP is Vl + V6, the specific radioactivity of the PEP formed is initially 1/(Vl+ VO), C4-glucose giving Cl -PEP and so on. Now, aspyruvate is only formed from PEP, pyruvate has the same specific radioactivity as PEP, i.e. label flows into pyruvate at the rate: V1/( Vl + V6). But when pyruvate was substrate the flow was defined as V1. Consequently the specific radioactivities in the system relative to unit flow of label into PEP are those given by the equations for pyruvate as substrate all divided by (Vl + V6).
Suppose glucose 6-phosphate is of unit specific radioactivity and singly labelled. Then the rate of flow of label to PEP is 0 5V5 (Scheme 1). Hence to obtain specific radioactivities relative to that of glucose 6-phosphate the equations should be multiplied by 0.5 V5/(Vi + V6). For example, with C5-glucose as primary substrate, on non-sym. case B, the specific radioactivity of C5-glutamate is given by: 0 5 V5GIu(5)/(ViL + V6) (3.68) where Glu(5) is given by eqn. (3.53).
For pyruvate, similarly, the total relative specific radioactivity is given by the pyruvate/(glucose 6-phosphate) specific-radioactivity ratio: 0-5V5[1 +PP(1) +PP (2) For uniformly labelled glucose 6-phosphate as substrate the equations for Cl-, C2-and C3-pyruvate should be added, and multiplied by V5/6(V1 + V6). The pyruvate/(glucose 6-phosphate) specific-radioactivity ratio is given by:
V[3 +PP(1) +PP(2) +PP(3)]/6( V1 + V6) (3.70)
It is therefore only necessary to list the equations for the pyruvates, as those for glucose can be easily obtained in the way described.
General comments. In the sym. case a factor E is obtained, relating the labelling in the ith turn of the tricarboxylic acid cycle to the label in the (i -1)th turn, for i > 2, just as E(1) does in non-sym. case B. E is not the same as E(1). This casts some doubt on the validity of adding the cases as suggested in this section, paragraph (3). The numerical differences between E(1) and E are, however, always very small, so any error can easily be shown to be small also. For non-sym. case A the corresponding factor is identical with that for the sym. case. These two cases can be added with no possibility of error. Simplification of the ba8ic 8cheme. The theory depends on certain assumptions.
(1) At least half of the label passing through 2-oxoglutarate equilibrates with glutamate (see above under '1. Pathways'). Two cases are worked out: for complete equilibration and for partial equilibration.
(2) The reactions oxaloacetate --aspartate and 2-oxoglutarate -+ glutamate will be assumed to proceed at the same absolute rates, on the grounds that both reactions are linked via L-aspartate aminotransferase. Other transferases also catalyse these reactions, so the approximation will lead to error unless Assumption (1) holds.
(3) The whole free glutamate and aspartate pools are involved, i.e. there is no compartmentation.
(4) As there is partial equilibrium between glutamine and glutamate (Waelsch, Berl, Rossi, Clarke & Purpura, 1964) , half the free glutamine is assumed to be in the glutamate pool for the purposes of calculation. This is the 'best-strategy' assumption to make about an unknown degree of partial equilibrium. Errors in this assumption cannot cause errors greater than 20% on one variable (kg).
(5) The only pools big enough to include are aspartate and glutamate (including half the glutamine).
(6) Some label leaves the tricarboxylic acid cycle via malate and returns via pyruvate. This process is neglected to simplify the mathematics. A trial computation suggests that this simplification has very little effect on numerical results.
Complete equilibration between glutamate and 2-oxoglutarate. The basic assumptions lead to the scheme shown in Scheme 9. Material passes through successive pools ofglutamate, each pool representing one turn of the cycle; and through aspartate, each representing the extra-(tricarboxylic acid cycle) system associated with the corresponding turn of the tricarboxylic acid cycle. To reconcile the treatment with that of the steady state the first glutamate pool is denoted by (0), i.e. zeroth turn and so on. Scheme 9. Kinetic scheme for non-steady-state theory corresponding to Scheme 1 for steady-state theory.
There are some simplifying approximations (see the text). 
(non-sym. case A), zo=0 5 (0.5 non-sym. case B) and 1 -zo-z = 0 5 (0 5 sym. case). For Glu(n) add all the equations for i = 0 for both the sym. case and non-sym. case B, and multiply by 0 5. Convert for comparison with glucose 6-phosphate by multiplying by V5/6( Vi + V6) ( To proceed further ag must be split into its constituent parts. (The following verbal definition is imperfect, and must be interpreted in the light of the subsequent equations.) Define ag(n,i) as the contribution made to the specific radioactivity of glutamate by label passing through glutamate for the (n + 1)th time and round the tricarboxylic acid cycle for the ith time. It follows that i cannot be less than n. Then the specific radioactivity of glutamate is given by: Eqn. (4.30) implies that of the label passing through 2-oxoglutarate the fraction (1 -,) emerges with the time-dependence of the input, f (t), and passes round the tricarboxylic acid cycle as though it had never entered glutamate. It therefore provides an input for the first turn of the cycle of (1 -j8)Wg(1)Fg(t), i.e.: To extend the treatment to higher values of n proceed as follows. Calculate from ag(p -l'P -1), i.e. ag(n,i) where n = i = p-1, ag(p,p) by: Table 1 for n up to 8. Wg (2) Wg (3) Wg (4) Wg (5) Wg (6) Wg (7) Wg (8) p+l= 11+1= Wa (2) Wa (3) Wa (4) Wa (5) Wa (6) Wa (7) Wa ( As the series all converge fairly rapidly, there is often no need to sum beyond ag(8,8), or for t < 30min. beyond a,(7,7).
This treatment imposes no limitations on the degree of equilibration. If, however, Assumption (2) (see above under 'Simplification of the basic scheme') is to be a reasonable approximation fi should probably be at least 0.5. (It should be noted that within the square brackets is ,, not PBa) Similarly:
To calculate a,(i) when i> 1, denoting specific values of n and i by p, it can be shown that:
where f[Pl,Wj(i)] is given in Table 1 .
The same approach can be used to calculate the rate of 14CO2 excretion. This is not discussed here. DISCUSSION Label can move without net movement of compound (exchange). The scheme was chosen to allow for this to the extent that seemed plausible under physiological conditions. It was not intended that the scheme should be used unmodified for systems in which the substrate concentrations were grossly unphysiological. Was the allowance adequate?
'Exchange' can refer to such things as the transfer of label from acetyl-CoA to glucose, although there can be no net synthesis of glucose from acetyl-CoA. This type of exchange was fully covered by the randomization and symmetrization processes introduced (Schemes 4-6).
Exchange also refers to transfer of label by the reversal of reactions, so that, e.g., in the closed system malate = oxaloacetate at equilibrium label introduced as malate will eventually confer equal specific radioactivities on malate and oxaloacetate without net conversion of malate into oxaloacetate.
If the whole tricarboxylic acid cycle consisted of such reversible processes then label could move round it both ways, although the net flow is only in one. In the tricarboxylic acid cycle, however, exchange has been fully allowed for if two reactions, 2-oxoglutarate -* succinate and succinate -* fumarate, are irreversible; and some reversibility in the first is acceptable. All tricarboxylic acidcycle reactions can be made to reverse, but labelling experiments suggest that under physiological conditions succinate -÷ fumarate does not, as even when mitochondria are treated with unphysiologically high concentrations of labelled malate label only appears slowly in succinate (Walter et al. 1966) . Consider the cycle in the forward direction. The system fumarate, malate and oxaloacetate was treated as an exchanging system, all possible cases being covered by combinations of the sym. case and non-sym. cases A and B (all three compounds in equilibrium, or either adjacent pair with the third not). In the system oxaloacetate + acetylCoA = ... 2-oxoglutarate no label changes its position in either direction. As label only originates in acetyl-CoA and oxaloacetate, if label returns from 2-oxoglutarate to these compounds it is as though it had never left them. The kinetics are controlled entirely by the net output rates, R-A from 2-oxoglutarate and A from glutamate. Only if the reaction 2-oxoglutarate -* succinate is reversible is labelling affected, because succinate formation is accompanied by symmetrization. This will lead to more equality between C3-and C2-labelling in glutamate when C2-pyruvate is the substrate than would be the case if the reaction was irreversible. Heath & Threlfall (1968) show that this effect must be small. In glutamate only the distribution of label is affected: the total specific radioactivity of glutamate is not. It has been assumed that retrograde transfer of label from succinate to oxaloacetate is negligible, as the chain is very long.
Outside the tricarboxylic acid cycle it is a reasonable assumption that the overall reaction pyruvate -* acetyl-CoAis irreversible, and Heath & Threlfall (1968) adduce confirmatory evidence. 'PEP' was stated to include any triose phosphates in the glycolytic and gluconeogenic chains with which it was in equilibrium (see under '1. Pathways' in the Theory section), so the requirements for V5 and V6 are that each should represent any one irreversible step in the glycolytic and gluconeogenic chains respectively. Threlfall & Heath (1968) adduced evidence that there are such steps. The reasoning which suggests that the transfer of malate to the cytoplasm is substantially irreversible is given by Heath & Threlfall (1968) Ifthe reaction is reversible, however, the interpretation of the rates V2 and Vs is different. These rates represent the net rates of utilization of oxaloacetate formed directly from pyruvate by the tricarboxylic acid cycle and by the cytoplasmic system respectively. These are necessarily equal to the net rates of oxaloacetate formation by the two pathways, but these are less than the forward rates.
There remain two more doubtful cases, namely the oxaloacetate -+ PEP and PEP -+ pyruvate reactions. Both are known to be reversible. The first is known to equilibrate heavily in favour of PEP (see under '1. Pathways' in the Theory section). The second is generally believed to equilibrate heavily in favour of pyruvate (see under ' 1. Pathways' in the Theory section and the study by Kerson, Garfinkel & Mildvan, 1967) , but this view has been contested by Krimsky (1959) and Hoberman & d'Adamo (1960) . Hoberman & d'Adamo (1960) attributed the preponderance of C5-over C6-labelling in glucose in starved rats given C2-lactate (statement 2.6) to the reversal of the pyruvate kinase reaction, and assumed that label passing through oxaloacetate was necessarily completely symmetrized. I have carried out detailed computations to see what would happen if both the PEP kinase and pyruvate kinase reactions were reversible. They showed that, to affect anything by more than a few per cent, the back reactions would have to be comparable in rate with the net forward reactions, which is, of course, inconsistent with equilibria strongly favouring the forward reactions; and to explain the results obtained by Hoberman & d'Adamo (1960) Table, this is because there is no labelling, e.g. there is no C2,3-labelling in aspartate from Cl-pyruvate, so there is no entry for C2,3-aspartate.
The specific radioactivities of aspartate, glutamate and phosphoenolpyruvate are denoted by the abbreviations used in eqns. (3.44)-(3.53) of the main paper. The specific radioactivity of carbon dioxide from C(n-labelled)-pyruvate is denoted by Cn (see under '3. Steady-state theory:
C2-pyruvate, non-sym. case B' in the Theory section of the main paper).
After the Tables various additional equations are of the main paper) to be calculated, and the given that enable relative specific radioactivities equations for labelled glucose 6-phosphate as and yields (see under '3. Steady-state theory: C2-substrate to be developed. pyruvate, non-sym. case B' in the Theory section PP (1) (1-ac)BC2
0O5D The equations appear different at first sight, as they are presented in a form close to that from which a computer programme has been prepared. 
1AB(1) F(19).D(2) E(1).F(19).D(2)
Glu ( Relative specific radioactivities in the steady state. case A, or by [1 -E(1)] for non-sym. case B, and For each compound and positioln of label divide the add the result. to the entries under i = 0 and i= 1. entry under i = 2 by (1 -E) for sym. case or non-sym. Denote by f(S).
LABELLING IN CARBOHYDRATE METABOLISM
For pyruvate as substrate, the specific radioactivity of pyruvate, P, is: P = 1 +PP(1) +PP(2) +PP(3) (A.1)
Specific radioactivities relative to pyruvate are given by f(S)/P. For glucose as substrate specific radioactivities can be calculated relative to that of glucose 6-phosphate. For C4-, C5-and C6-glucose as substrate use the f(S) values for Cl-, C2-and C3-pyruvate. For the specific radioactivity of pyruvate relative to that of glucose 6-phosphate, if glucose is C(n)-labelled then, for P(n): For mixed cases, i.e. partial symmetrization, see under '3. Steady-state theory' in the Theory section of the main paper.
Relative labelling in C4, C5 and C6 of glucose formed from pyruvate is given by the relative values of PP(1), PP(2) and PP(3) (statement 2.1 in the main paper). 
